A share price of HCW Biologics Inc [HCWB] is currently trading at $5.89, up 6.13%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HCWB shares have gain 65.45% over the last week, with a monthly amount glided 41.93%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
HCW Biologics Inc experienced fluctuations in its stock price throughout the past year between $2.77 and $100.80. HCW Biologics Inc [NASDAQ: HCWB] shares were valued at $5.89 at the most recent close of the market.
Analyzing the HCWB fundamentals
Trailing Twelve Months sales for HCW Biologics Inc [NASDAQ:HCWB] were 0.83M which represents -98.94% decline. Gross Profit Margin for this corporation currently stands at -0.62% with Operating Profit Margin at -14.74%, Pretax Profit Margin comes in at -25.88%, and Net Profit Margin reading is -25.88%. To continue investigating profitability, this company’s Return on Assets is posted at -0.75, Equity is 3.4 and Total Capital is -5.95. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-123.55.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.15 points at the first support level, and at 4.41 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.32, and for the 2nd resistance point, it is at 6.75.
Ratios To Look Out For
To put it in perspective, the Current Ratio for HCW Biologics Inc [NASDAQ:HCWB] is 0.11. In addition, the Quick Ratio stands at 0.11 and the Cash Ratio stands at 0.09. Considering the valuation of this stock, the price to sales ratio is 15.27.
Transactions by insiders
Recent insider trading involved Wong Hing C, Chief Executive Officer, that happened on May 16 ’25 when 8054.0 shares were purchased. Director, Winer Gary M completed a deal on May 16 ’25 to buy 1342.0 shares. Meanwhile, Director GARRETT SCOTT T bought 13423.0 shares on May 16 ’25.
